A new study has provided precise atomic data that shed light on the impact of charged ions from coronal mass ejections (CMEs) ...
1 天
Zacks Investment Research on MSNIONS Out-Licenses ex-U.S. Rights for Rare Disease Drug Tryngolza to SobiIonis Pharmaceuticals IONS signed a license agreement with Sweden-based Sobi. Per the terms, Sobi will acquire exclusive ...
2 天on MSN
We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...
Olezarsen目前正在接受欧洲药品管理局对FCS治疗的审查,预计将在今年内获得批准。Sobi在超过30个国家拥有商业存在,将负责在其区域内的监管提交和商业化,并借助其在Waylivra®(欧洲唯一获批的FCS药物)方面的经验。Ionis将从Sobi获得预付款、基于里程碑的付款,以及高达20%中段的年度净销售额分级特许权使用费。
The oceans hold an enormous amount of very diluted uranium that could potentially serve as a sustainable fuel source for ...
A new study has provided precise atomic data that sheds light on the impact of charged ions from Coronal Mass Ejections (CMEs ...
Natixis Advisors LLC lowered its stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 32.1% during ...
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with ...
Our work on entangling two calcium ions in buildings 230 meters apart was published in Physical Review Letters.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果